BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Policy

  Pfizer Inc. Unit Quigley Pharma Inc. To Exit Ch. 11 With $265M Asbestos Settlement

  March 23, 2011

   · 

  1 min read
• Drug Development

  Omeros Corporation Ophthalmology Product OMS302 Achieves Co-Primary Endpoints in Phase 2b Clinical Study

  March 23, 2011

   · 

  6 min read
• Deals

  St. Jude Medical Surges on Note Praising New Device

  March 23, 2011

   · 

  1 min read
• Policy

  ReGen Biologics, Inc. to FDA: ‘Thanks, But No Thanks’

  March 23, 2011

   · 

  5 min read
• Lone Star Bio

  Asuragen, Inc. Launches CE Marked IVD AmplideX(TM) Fragile X Test in Europe

  March 23, 2011

   · 

  3 min read
• Pharm Country

  Millar Instruments, Inc., H&P Industries Issue Recalls

  March 23, 2011

   · 

  1 min read
• Deals

  Teleflex Medical Sells Marine Business for $121.6 Million

  March 23, 2011

   · 

  3 min read
• Biotech Bay

  BayBio (Bay Area Bioscience Association) Hosts Career Fair with BioSpace and BHRN at BayBio2011 Annual Conference

  March 23, 2011

   · 

  2 min read
• Drug Development

  Phase III Clinical Trial of Gilead Sciences, Inc.’s Investigational Elvitegravir Meets 48-Week Primary Objective

  March 23, 2011

   · 

  5 min read
• Pharm Country

  Nanomodified Surfaces Seal Leg Implants Against Infection, Brown University Study

  March 23, 2011

   · 

  3 min read